| 1 |
32821125 |
10.2147/OTT.S258365 |
2022 |
<i>SET-CAN</i> Fusion Gene in Acute Leukemia and Myeloid Neoplasms: Report of Three Cases and a Literature Review. |
BCOR |
| 2 |
34057377 |
10.1177/10668969211021997 |
2022 |
<i>CRTC1-SS18</i> Fusion Sarcoma With Aberrant Anaplastic Lymphoma Kinase Expression. |
BCOR |
| 3 |
34180720 |
10.1177/10668969211027409 |
2022 |
Aggressive Cyclin D1 Negative Blastoid Variant Mantle Cell Lymphoma-A Case Report. |
BCOR |
| 4 |
34265801 |
10.1097/PAS.0000000000001780 |
2022 |
Plasticity of Mature B Cells Between Follicular and Classic Hodgkin Lymphomas: A Series of 22 Cases Expanding the Spectrum of Transdifferentiation. |
BCOR |
| 5 |
34414699 |
10.1631/jzus.B2000797 |
2022 |
LG-ESSs and HG-ESSs: underlying molecular alterations and potential therapeutic strategies. |
BCOR |
| 6 |
34749754 |
10.1186/s13000-021-01166-4 |
2022 |
Primary breast CD20-positive extranodal NK/T cell lymphoma with stomach involvement: a case report and literature review. |
BCOR |
| 7 |
34957890 |
10.1080/10428194.2021.2015587 |
2022 |
Loss of function mutations of <i>BCOR</i> in classical Hodgkin lymphoma. |
BCOR |
| 8 |
34980830 |
10.1097/PAS.0000000000001859 |
2022 |
Clinicopathologic and Genetic Features of Primary T-cell Lymphomas of the Central Nervous System: An Analysis of 11 Cases Using Targeted Gene Sequencing. |
BCOR |
| 9 |
35592856 |
10.3389/fmed.2022.808378 |
2022 |
A Somatic Mutation Signature Predicts the Best Overall Response to Anti-programmed Cell Death Protein-1 Treatment in Epidermal Growth Factor Receptor/Anaplastic Lymphoma Kinase-Negative Non-squamous Non-small Cell Lung Cancer. |
BCOR |
| 10 |
35708139 |
10.3324/haematol.2022.281226 |
2022 |
Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome. |
BCOR |
| 11 |
35882439 |
10.1182/bloodadvances.2022007541 |
2022 |
Genetic and immunohistochemical profiling of NK/T-cell Lymphomas reveals prognostically relevant BCOR-MYC association. |
BCOR |
| 12 |
35920299 |
10.1096/fj.202200061RR |
2022 |
Mcm2 hypomorph leads to acute leukemia or hematopoietic stem cell failure, dependent on genetic context. |
BCOR |
| 13 |
35957990 |
10.3389/fphys.2022.946282 |
2022 |
Molecular mechanism of hyperactive tooth root formation in oculo-facio-cardio-dental syndrome. |
BCOR |
| 14 |
31822801 |
10.1038/s41379-019-0415-5 |
2021 |
Mutational profile and EBV strains of extranodal NK/T-cell lymphoma, nasal type in Latin America. |
BCOR |
| 15 |
32139296 |
10.1016/j.clml.2019.11.007 |
2021 |
Defining Acute Myeloid Leukemia Ontogeny in Older Patients. |
BCOR |
| 16 |
32527129 |
10.21037/apm-19-430b |
2021 |
Glans metastatic extra-nodal natural killer/T-cell lymphoma, nasal-type with HDAC inhibitor as maintenance therapy: a rare case report with literature review. |
BCOR |
| 17 |
32584970 |
10.1182/blood.2020005289 |
2021 |
Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes. |
BCOR |
| 18 |
33374737 |
10.3390/ijms22010074 |
2021 |
Pathogenic Impacts of Dysregulated Polycomb Repressive Complex Function in Hematological Malignancies. |
BCOR |
| 19 |
33468080 |
10.1186/s12885-021-07806-8 |
2021 |
The mutation of BCOR is highly recurrent and oncogenic in mature T-cell lymphoma. |
BCOR |
| 20 |
33491151 |
10.1007/s00381-020-05035-1 |
2021 |
Lenz microphthalmia syndrome in neurosurgical practice: a case report and review of the literature. |
BCOR |
| 21 |
33808787 |
10.3390/cancers13061414 |
2021 |
EBV and the Pathogenesis of NK/T Cell Lymphoma. |
BCOR |
| 22 |
34570179 |
10.1182/bloodadvances.2021004668 |
2021 |
Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies. |
BCOR |
| 23 |
28487787 |
10.1155/2017/5083463 |
2020 |
EBV-Negative Monomorphic B-Cell Posttransplant Lymphoproliferative Disorder with Marked Morphologic Pleomorphism and Pathogenic Mutations in <i>ASXL1</i>, <i>BCOR</i>, <i>CDKN2A</i>, <i>NF1</i>, and <i>TP53</i>. |
BCOR |
| 24 |
30618304 |
10.1080/10428194.2018.1543885 |
2020 |
<i>BCOR</i> and <i>BCORL1</i> mutations in myelodysplastic syndromes (MDS): clonal architecture and impact on outcomes. |
BCOR |
| 25 |
30917298 |
10.1177/0022034519837248 |
2020 |
Mutational Signatures in Mandibular Ameloblastoma Correlate with Smoking. |
BCOR |
| 26 |
30992267 |
10.1182/blood.2018864173 |
2020 |
Engineered Bcor mutations lead to acute leukemia of progenitor B-1 lymphocyte origin in a sensitized background. |
BCOR |
| 27 |
31221981 |
10.1038/s12276-019-0230-6 |
2020 |
The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism. |
BCOR |
| 28 |
31285322 |
10.1073/pnas.1905305116 |
2020 |
Nbn-Mre11 interaction is required for tumor suppression and genomic integrity. |
BCOR |
| 29 |
31334109 |
10.3389/fonc.2019.00568 |
2020 |
Dynamic Changes in Gene Mutational Landscape With Preservation of Core Mutations in Mantle Cell Lymphoma Cells. |
BCOR |
| 30 |
29974297 |
10.1007/s00439-018-1896-x |
2019 |
Expanding the phenotype of the X-linked BCOR microphthalmia syndromes. |
BCOR |
| 31 |
29989027 |
10.18632/oncotarget.25601 |
2019 |
New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes. |
BCOR |
| 32 |
30228234 |
10.1182/blood-2018-01-827964 |
2019 |
<i>Bcor</i> insufficiency promotes initiation and progression of myelodysplastic syndrome. |
BCOR |
| 33 |
31196877 |
10.1182/blood.2019001249 |
2019 |
B-1 progenitor acute lymphoid leukemia. |
BCOR |
| 34 |
27562494 |
10.1038/modpathol.2016.155 |
2018 |
ETV4 is a useful marker for the diagnosis of CIC-rearranged undifferentiated round-cell sarcomas: a study of 127 cases including mimicking lesions. |
BCOR |
| 35 |
27880939 |
10.18632/oncotarget.13477 |
2018 |
Inhibition of the transcriptional repressor complex Bcl-6/BCoR induces endothelial sprouting but does not promote tumor growth. |
BCOR |
| 36 |
28256570 |
10.1038/modpathol.2017.12 |
2018 |
Recurrent BCOR internal tandem duplication and BCOR or BCL6 expression distinguish primitive myxoid mesenchymal tumor of infancy from congenital infantile fibrosarcoma. |
BCOR |
| 37 |
28262675 |
10.1038/ncomms14581 |
2018 |
Genomic characterisation of Eμ-Myc mouse lymphomas identifies Bcor as a Myc co-operative tumour-suppressor gene. |
BCOR |
| 38 |
28751561 |
10.3324/haematol.2016.160192 |
2018 |
Exome sequencing identifies recurrent <i>BCOR</i> alterations and the absence of <i>KLF2</i>, <i>TNFAIP3</i> and <i>MYD88</i> mutations in splenic diffuse red pulp small B-cell lymphoma. |
BCOR |
| 39 |
29293322 |
10.1021/acs.biochem.7b00732 |
2018 |
Discovery of an Irreversible and Cell-Active BCL6 Inhibitor Selectively Targeting Cys53 Located at the Protein-Protein Interaction Interface. |
BCOR |
| 40 |
29427188 |
10.1007/s00277-018-3267-z |
2018 |
Molecular characteristic of acute leukemias with t(16;21)/FUS-ERG. |
BCOR |
| 41 |
29661713 |
10.1016/j.anndiagpath.2017.11.011 |
2018 |
Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, undifferentiated small round cell tumors. A clinicopathologic, immunophenotypic and molecular analysis. |
BCOR |
| 42 |
30126017 |
10.1002/gcc.22648 |
2018 |
Preoperative diagnosis of clear cell sarcoma of the kidney by detection of BCOR internal tandem duplication in circulating tumor DNA. |
BCOR |
| 43 |
30134235 |
10.1159/000492835 |
2018 |
Frequent Mutations in Natural Killer/T Cell Lymphoma. |
BCOR |
| 44 |
27470916 |
10.1111/bjh.14247 |
2017 |
Whole-exome sequencing reveals the spectrum of gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia. |
BCOR |
| 45 |
27505670 |
10.1016/j.ccell.2016.07.006 |
2017 |
EZH2 and BCL6 Cooperate to Assemble CBX8-BCOR Complex to Repress Bivalent Promoters, Mediate Germinal Center Formation and Lymphomagenesis. |
BCOR |
| 46 |
27856253 |
10.1016/j.bbrc.2016.11.060 |
2017 |
Discovery of high-affinity BCL6-binding peptide and its structure-activity relationship. |
BCOR |
| 47 |
28063196 |
10.1002/gcc.22443 |
2017 |
ASXL2 mutations are frequently found in pediatric AML patients with t(8;21)/ RUNX1-RUNX1T1 and associated with a better prognosis. |
BCOR |
| 48 |
28368400 |
10.1038/onc.2017.85 |
2017 |
Interferon γ is a STAT1-dependent direct inducer of BCL6 expression in imatinib-treated chronic myeloid leukemia cells. |
BCOR |
| 49 |
28440018 |
10.1002/pbc.26602 |
2017 |
Clear cell sarcoma of kidney involving a horseshoe kidney and harboring EGFR internal tandem duplication. |
BCOR |
| 50 |
28471657 |
10.1021/acs.jmedchem.7b00313 |
2017 |
Discovery of a B-Cell Lymphoma 6 Protein-Protein Interaction Inhibitor by a Biophysics-Driven Fragment-Based Approach. |
BCOR |
| 51 |
28694326 |
10.1182/blood-2017-02-768234 |
2017 |
Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E). |
BCOR |
| 52 |
28760529 |
10.1016/j.bmc.2017.07.037 |
2017 |
Discovery of a novel B-cell lymphoma 6 (BCL6)-corepressor interaction inhibitor by utilizing structure-based drug design. |
BCOR |
| 53 |
28827447 |
10.1084/jem.20170167 |
2017 |
Internal deletion of BCOR reveals a tumor suppressor function for BCOR in T lymphocyte malignancies. |
BCOR |
| 54 |
25980440 |
10.18632/oncotarget.3776 |
2016 |
Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type. |
BCOR |
| 55 |
26773734 |
10.1002/gcc.22348 |
2016 |
Frequent BCOR aberrations in extranodal NK/T-Cell lymphoma, nasal type. |
BCOR |
| 56 |
26917488 |
10.1111/bjh.13952 |
2016 |
Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia. |
BCOR |
| 57 |
27013922 |
10.2174/1389202916666151014221954 |
2016 |
Genetics of Bladder Malignant Tumors in Childhood. |
BCOR |
| 58 |
24325634 |
10.3109/10428194.2013.874009 |
2015 |
BCL6 corepressor gene dysregulation due to chromosomal translocation in acute myeloid leukemia: a new mechanism based on long non-coding RNA dislocation? |
BCOR |
| 59 |
25105937 |
10.1097/PAP.0000000000000036 |
2015 |
Round cell tumors of bone: an update on recent molecular genetic advances. |
BCOR |
| 60 |
25331958 |
10.1074/jbc.M114.571182 |
2015 |
Interferon regulatory factor 8 (IRF8) interacts with the B cell lymphoma 6 (BCL6) corepressor BCOR. |
BCOR |
| 61 |
25490446 |
10.1016/j.ccell.2014.10.021 |
2015 |
A BCL6/BCOR/SIRT1 complex triggers neurogenesis and suppresses medulloblastoma by repressing Sonic Hedgehog signaling. |
BCOR |
| 62 |
23669349 |
10.1093/hmg/ddt211 |
2014 |
Bcl6a function is required during optic cup formation to prevent p53-dependent apoptosis and colobomata. |
BCOR |
| 63 |
23911289 |
10.1016/j.celrep.2013.06.016 |
2014 |
A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters. |
BCOR |
| 64 |
24220571 |
10.1016/j.humimm.2013.10.004 |
2014 |
Allospecific CD8 T suppressor cells induced by multiple MLC stimulation or priming in the presence of ILT3.Fc have similar gene expression profiles. |
BCOR |
| 65 |
24793055 |
10.1016/j.jmgm.2014.04.003 |
2014 |
Molecular dynamics analysis of the interaction between the human BCL6 BTB domain and its SMRT, NcoR and BCOR corepressors: the quest for a consensus dynamic pharmacophore. |
BCOR |
| 66 |
23897248 |
10.1309/AJCPHPVH4M7MTWUN |
2013 |
Immunoarchitectural patterns of germinal center antigens including LMO2 assist in the differential diagnosis of marginal zone lymphoma vs follicular lymphoma. |
BCOR |
| 67 |
23913470 |
10.1182/blood-2013-02-485441 |
2013 |
Sirtuin and pan-class I/II deacetylase (DAC) inhibition is synergistic in preclinical models and clinical studies of lymphoma. |
BCOR |
| 68 |
21544546 |
10.1007/s00018-011-0695-5 |
2011 |
The multiple roles of Notch signaling during left-right patterning. |
BCOR |
| 69 |
20230751 |
10.1016/j.devcel.2009.12.023 |
2010 |
BCL6 canalizes Notch-dependent transcription, excluding Mastermind-like1 from selected target genes during left-right patterning. |
BCOR |
| 70 |
20385364 |
10.1016/j.ccr.2009.12.050 |
2010 |
A small-molecule inhibitor of BCL6 kills DLBCL cells in vitro and in vivo. |
BCOR |
| 71 |
18779728 |
10.1097/PAS.0b013e31817f123e |
2009 |
Peripheral T-cell lymphoma with follicular T-cell markers. |
BCOR |
| 72 |
18212045 |
10.1128/MCB.01400-07 |
2008 |
CtBP is an essential corepressor for BCL6 autoregulation. |
BCOR |
| 73 |
18280243 |
10.1016/j.molcel.2007.12.026 |
2008 |
Structure of a BCOR corepressor peptide in complex with the BCL6 BTB domain dimer. |
BCOR |
| 74 |
16133367 |
10.1007/s00428-005-0041-0 |
2006 |
Molecular cytogenetic characterization of an ins(4;X) occurring as the sole abnormality in an aggressive, poorly differentiated soft tissue sarcoma. |
BCOR |
| 75 |
16249378 |
10.1182/blood-2005-04-1629 |
2006 |
BCL6 is regulated by p53 through a response element frequently disrupted in B-cell non-Hodgkin lymphoma. |
BCOR |
| 76 |
15531890 |
10.1038/nm1134 |
2005 |
Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells. |
BCOR |
| 77 |
10898795 |
|
2000 |
BCoR, a novel corepressor involved in BCL-6 repression. |
BCOR |
Datasets
Models
